CONSULTING AGREEMENTConsulting Agreement • January 4th, 2024 • Arbutus Biopharma Corp • Pharmaceutical preparations • Pennsylvania
As a condition of becoming retained by Arbutus Biopharma Corporation, a British Columbia corporation, Arbutus Biopharma Inc., a Delaware Corporation, or any of its current or future subsidiaries, affiliates, successors or assigns (collectively, “Arbutus”), and in consideration of Consultant’s consulting relationship with Arbutus and receipt of the compensation now and hereafter paid by Arbutus, Consultant hereby agrees to the following:
Separation and Release Agreement By and Between William Collier and Arbutus Biopharma Corporation.Separation and Release Agreement • January 4th, 2024 • Arbutus Biopharma Corp • Pharmaceutical preparations • Pennsylvania
This Confidential Separation and Release Agreement (“Agreement”) is entered into between William Collier (“Executive”) and Arbutus Biopharma Corporation and is in consideration of the mutual undertakings set forth below.
FOURTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 4th, 2024 • Arbutus Biopharma Corp • Pharmaceutical preparations • Pennsylvania
This Fourth Amendment to Executive Employment Agreement (this “Amendment”) is made effective as of January 1, 2024 (the “Effective Date”) by and between Arbutus Biopharma, Inc. (the “Company”), and Michael McElhaugh (the “Executive”) (together the “Parties”).
